George McCoy, a longtime patient at the UNC Hemophilia & Thrombosis Center and the first man in the world to receive recombinant clotting factor, was the subject of a news story on WTVD on February 16.
Mr. McCoy has been involved in cutting-edge research in bleeding disorders at UNC-Chapel Hill for many years. As the first person in the world to receive the man-made clotting factors back in 1987, he helped pave the way for what is now the current standard treatment. And now, he’s once again on the frontlines of the latest advancement in treatment, currently taking the next generation of man-made clotting factors which allow patients to go longer between infusions.
Here is a link to the full story and video: http://abc11.com/health/local-man-at-forefront-of-hemophilia-research/1202659/